Biocryst Pharmaceuticals Inc (BCRX)

Add to Watchlists
Create an Alert
2.69 +0.01  +0.37% NASDAQ Aug 20, 16:39 Delayed 2m USD

Biocryst Pharmaceuticals Net Income (Quarterly):

-37.63M for June 30, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Net Income (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Net Income (Quarterly) Data

View and export this data going back to 1994. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2019 -37.63M
March 31, 2019 -31.05M
Dec. 31, 2018 -27.43M
Sept. 30, 2018 -29.60M
June 30, 2018 -18.45M
March 31, 2018 -25.78M
Dec. 31, 2017 -19.54M
Sept. 30, 2017 -15.13M
June 30, 2017 -16.89M
March 31, 2017 -14.22M
Dec. 31, 2016 -4.503M
Sept. 30, 2016 -11.53M
June 30, 2016 -16.28M
March 31, 2016 -22.83M
Dec. 31, 2015 -18.14M
Sept. 30, 2015 -14.62M
June 30, 2015 4.901M
March 31, 2015 -15.16M
Dec. 31, 2014 -11.67M
Sept. 30, 2014 -8.731M
June 30, 2014 -14.65M
March 31, 2014 -10.14M
Dec. 31, 2013 -5.429M
Sept. 30, 2013 -8.001M
June 30, 2013 -12.17M
   
March 31, 2013 -4.506M
Dec. 31, 2012 -11.05M
Sept. 30, 2012 -9.70M
June 30, 2012 -12.28M
March 31, 2012 -6.052M
Dec. 31, 2011 -13.19M
Sept. 30, 2011 -14.46M
June 30, 2011 -16.27M
March 31, 2011 -13.03M
Dec. 31, 2010 -10.20M
Sept. 30, 2010 -10.86M
June 30, 2010 -10.19M
March 31, 2010 -2.595M
Dec. 31, 2009 15.15M
Sept. 30, 2009 -10.63M
June 30, 2009 -8.684M
March 31, 2009 -9.292M
Dec. 31, 2008 10.07M
Sept. 30, 2008 -8.995M
June 30, 2008 -12.71M
March 31, 2008 -13.10M
Dec. 31, 2007 -2.284M
Sept. 30, 2007 -10.98M
June 30, 2007 -6.963M
March 31, 2007 -8.825M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Net Income

Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.

Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More

Advertisement

Net Income (Quarterly) Benchmarks

Benchmarks
MiMedx Group Inc 17.46M
Innovate Biopharmaceuticals Inc -4.488M
Obalon Therapeutics Inc -6.767M

Net Income (Quarterly) Range, Past 5 Years

Minimum -37.63M Jun 2019
Maximum 4.901M Jun 2015
Average -17.71M

Net Income (Quarterly) Excel Add-In Codes

  • Metric Code: net_income
  • Data Point Example: =YCP("BCRX", "net_income")
  • Data Series Example: =YCS("BCRX", "net_income", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.